Boehringer Ingelheim has received a breakthrough therapy designation from the US Food and Drug Administration (FDA) for ...

Boehringer Ingelheim’s weight-loss drug candidate ... dysfunction-associated steatotic liver disease (MASLD), which in turn has been rebranded from non-alcoholic fatty liver disease (NAFLD).

By Noah Weiland and Rebecca Robbins Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim’s generic drugs business in the U.S. had lower-than-expected sales.

They’re still a little expensive compared to their fixed-bed cousins though, so if you hanker for a Creality CR30 but only have the cash for an Ender 3, [Michael Sgroi] may have the project for you.

The heritage of Boehringer Ingelheim in developing ... leading to widening of the airways, which, in turn, improves expiratory flow 3. Since obstruction of the airways and associated symptoms ...

She's currently the Chief Medical Officer and Head of Medicine at Boehringer Ingelheim. Well ... meaning that we are looking to turn cold tumors into hot tumors. And we do that through cancer ...

A group of people fights for their survival against a family of hideously deformed inbred cannibals who plan to ruthlessly butcher them all.

Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement ... 1 accounting for up to 20 million deaths annually.2,3 The intricate connection between the CRM systems signifies that disease ...

Boehringer Ingelheim, through our ‘Taking Cancer On ... Overall, approximately 5–7% of tumours display MDM2 amplifications 3 . However, such amplifications are more common in some tumour ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

It costs a lot more to throw a wedding than it did a few years ago — the national average is $35,000 in 2024, compared with $28,000 in 2021. But the cost to attend a wedding has gone up even ...

Researchers from the School of Veterinary Medicine and Perelman School of Medicine have found that YY1 knockout pro-B cells can generate T lineage cells helping B cells produce antibodies.